Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3) Financial Statements
Profarma Distribuidora de Produtos Farmaceuticos SA Financial Overview
Profarma Distribuidora de Produtos Farmaceuticos SA's market cap is currently $825.17M. The company's EPS TTM is $1.27; its P/E ratio is 5.32; and it has a dividend yield of 9.57%. Profarma Distribuidora de Produtos Farmaceuticos SA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.45B | $ 10.15B | $ 8.66B | $ 7.82B | $ 6.41B |
| Gross Profit | $ 1.75B | $ 1.52B | $ 1.29B | $ 1.15B | $ 907.57M |
| Operating Income | $ 381.63M | $ 254.34M | $ 245.62M | $ 228.68M | $ 100.39M |
| EBITDA | $ 581.79M | $ 401.46M | $ 353.37M | $ 380.44M | $ 226.44M |
| Net Income | $ 118.90M | $ 114.58M | $ 70.40M | $ 80.87M | $ 78.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 235.12M | $ 229.55M | $ 193.74M | $ 183.25M | $ 188.52M |
| Total Assets | $ 6.23B | $ 5.62B | $ 4.94B | $ 4.36B | $ 4.03B |
| Total Debt | $ 1.40B | $ 1.25B | $ 1.14B | $ 1.02B | $ 946.88M |
| Net Debt | $ 1.17B | $ 1.02B | $ 949.96M | $ 840.94M | $ 758.37M |
| Total Liabilities | $ 4.60B | $ 4.03B | $ 3.40B | $ 2.85B | $ 2.56B |
| Stockholders' Equity | $ 1.35B | $ 1.30B | $ 1.25B | $ 1.19B | $ 1.09B |
| Cash Flow | |||||
| Free Cash Flow | $ 190.15M | $ 469.03M | $ 246.89M | $ 115.81M | $ 94.03M |
| Operating Cash Flow | $ 336.89M | $ 497.09M | $ 260.90M | $ 126.32M | $ 107.58M |
| Investing Cash Flow | $ -176.14M | $ -136.84M | $ -96.58M | $ -21.74M | $ -86.41M |
| Financing Cash Flow | $ -155.18M | $ -324.44M | $ -153.83M | $ -109.84M | $ -204.44M |
Currency in BRL